Navigation Links
Negative Cancer Messages Backfire With Blacks
Date:11/6/2008

gardless of the individual's level of mistrust."

"The positive message seemed to wipe out the differences between high and low mistrust levels," he said.

The results were published in the November issue of the journal Cancer Epidemiology, Biomarkers & Prevention.

Dr. Harvey J. Murff, an assistant professor of medicine at Vanderbilt University School of Medicine, who has done similar research, called the new findings "very interesting and useful."

"One message [about screening for cancer] is not going to be appropriate for all cultures and backgrounds," Murff said. The new findings underscore the need for public health officials who create messages for cancer screenings to frame them in a more positive way to get the desired result, he said.

Health officials who want to persuade more people to get screened for colon cancer could take a page from those who create messages to screen for breast cancer, which often take into account cultural differences, Murff said. Breast cancer screening has improved greatly over the years, he said, adding, "This has not been looked at as well in colon and rectal cancer."

More information

To learn more about colon and rectal cancer, visit the U.S. National Cancer Institute.



SOURCES: Robert Nicholson, Ph.D., assistant professor of neurology and psychiatry, St. Louis University, St. Louis, Mo.; Harvey J. Murff, M.D., assistant professor of medicine, Vanderbilt University School of Medicine, Nashville; November 2008, Cancer Epidemiology, Biomarkers & Prevention


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Surprisingly, female models have negative effect on men
2. Minority patients discouraged from cancer screening by negative messages
3. Media coverage of lung cancer is increasing, and increasingly negative, new report shows
4. Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer
5. Homosexuals negative feelings about sexuality predict poor mental and sexual health
6. New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons TOGETHER Launches Across the Nation
7. Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process
8. Both boys and girls negatively affected by sexual harassment
9. National Long Term Care Leaders to Release New Data, Discuss Negative National Economic, Jobs Impact
10. Study Shows Increased Out-of-Pocket Expenses May Negatively Influence Initiation of TNF Blocker Therapy
11. A diagnosis of triple-negative breast cancer doesnt always mean cancer spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...isk of developing liver cancer and more than twice...researchers based on findings of a recent study. ...agnosed with 12 different types of cancer to 509 h...pendent of other factors like participants' body m...
...researchers suggest that the risk factors for hear...nearly 2,000 teens studied, about two-thirds had a... as 10 percent had a cluster of risk factors known... heart disease and diabetes. For the purpose of th...
...tic hypotension have problems with sinking blood p.../ Current treatments help increase blood pressure ...r when lying down, increasing the risk for stroke....ic hypotension especially common in those over age...
...ncer death worldwide, accounting for more than 1.3...rd to detect in early and treatable stages, most c...tudies have shown CT scans can identify the diseas...ecent study, researchers used PET scans to confirm...
...benefit from early magnetic resonance imaging, acc...o neuroscientists in Canada MRI technology could d...ients. They say they found that trauma-induced spi...ly certain the procedure will benefit the patient,...
... in soy could be good for the hearts and bones of ...parate studies suggest the natural plant estrogens...the body's own estrogen, therefore making soy espe...tter cholesterol levels compared to monkeys who at...
Other Medicine News:Health News:New Drug Effective for Low Blood Pressure 2
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 1Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB 728 T for HIV AIDS 14909 2FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 1FREE Drug Discount Card Saves Money on Prescriptions and Raises Funds for Americas Disabled Veterans 6392 2Genital Herpes May Never Go Dormant 61659 1Genital Herpes May Never Go Dormant 61659 2Genital Herpes May Never Go Dormant 61659 3
...xpansion of Company,s Phase 3 Study for Wet AMD af...ata, FREMONT, Calif., April 17 NeoVista, Inc. an...ration (FDA) has granted the,company,s request to ...votal Phase 3 trial from 10 to 30 in the United St...ndary to AMD Treated with BEta RadiatioN,Epiretina...
...il 17 Innocoll, Inc., a privately-held,biopharmac...e planned phase,2 clinical trials sponsored by its...d, to investigate CollaRx(R) GENTAMICIN TOPICAL fo...c foot ulcers, has commenced,dosing. CollaRx GENTA...ble,Gentamicin-Collagen Sponge formulated and manu...
Other Medicine Technology:FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 2FDA Grants NeoVista's Request to Expand CABERNET Trial to 30 Sites in the U.S. 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers 4
...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
...s for performing erythrocyte sedimentation rate (E...on of the Ves-matic System DIESSE brings to the cl...ting system which addresses and resolves every tec...ESR techique.,By means of a fully automated analyz...
...ntation rate analysers, which are especially user-...well-established advantages of the existing analys...ch guarantee time-saving standardised analysis of ...ness is an essential aspect of daily recurrent rou...
Mix-Rate
Medicine Products: